Skip to main content

Thanks to Today's PIs: Nov 30, 2009

Premium

Reudi Aebersold
Swiss Federal Institute of Technology

Christopher Austin
National Human Genome Research Institute

Stephan Beck
University College London

Steven Brenner
University of California, San Diego

Arul Chinnaiyan
University of Michigan Medical School

George Church
Harvard University

Richard Durbin
Wellcome Trust Sanger Institute

Claire Fraser-Liggett
University of Maryland

Elaine Fuchs
Rockefeller University

David Goldstein
Duke University

Steven Henikoff
Fred Hutchinson Cancer Research Center

Winston Hide
Harvard University

Thomas Kelly
Memorial Sloan-Kettering Cancer Center

Isaac Kohane
Harvard University

Harris Lewin
University of Illinois at Urbana-Champaign

Susan Lindquist
Whitehead Institute

Andre Marziali
University of British Columbia

Elaine Ostrander
National Human Genome Research Institute

John Quackenbush
Dana-Farber Cancer Institute

Jaques Ravel
University of Maryland School of Medicine

John Reed
Burnham Institute for Medical Research

Bruce Stillman
Cold Spring Harbor Laboratory

Eric Topol
The Scripps Research Institute

Harold Varmus
Memorial Sloan-Kettering Cancer Center

John Yates
The Scripps Research Institute

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.